Currently, Oncomine database and Lung Cancer Genome Mapping database have shown that FGL1 mRNA is upregulated in lung cancer, prostate cancer, melanoma, and colorectal cancer tissues, but downregulated in pancreatic cancer, liver cancer and head and neck cancer, thereby indicating the involvement of FGL1 in these pathological states 8. The gene discussed is FGL1; the disease is lung carcinoma.